Health Catalyst Debt to Equity Ratio 2018-2024 | HCAT
Current and historical debt to equity ratio values for Health Catalyst (HCAT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Health Catalyst debt/equity for the three months ending September 30, 2024 was 0.32.
| Health Catalyst Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-09-30 | $0.46B | $0.36B | 1.29 |
| 2024-06-30 | $0.34B | $0.36B | 0.94 |
| 2024-03-31 | $0.34B | $0.36B | 0.95 |
| 2023-12-31 | $0.34B | $0.37B | 0.91 |
| 2023-09-30 | $0.33B | $0.38B | 0.86 |
| 2023-06-30 | $0.33B | $0.39B | 0.85 |
| 2023-03-31 | $0.35B | $0.41B | 0.86 |
| 2022-12-31 | $0.33B | $0.43B | 0.77 |
| 2022-09-30 | $0.34B | $0.44B | 0.76 |
| 2022-06-30 | $0.34B | $0.47B | 0.73 |
| 2022-03-31 | $0.34B | $0.48B | 0.72 |
| 2021-12-31 | $0.31B | $0.52B | 0.59 |
| 2021-09-30 | $0.30B | $0.55B | 0.54 |
| 2021-06-30 | $0.29B | $0.28B | 1.04 |
| 2021-03-31 | $0.30B | $0.27B | 1.13 |
| 2020-12-31 | $0.30B | $0.28B | 1.09 |
| 2020-09-30 | $0.27B | $0.30B | 0.91 |
| 2020-06-30 | $0.23B | $0.23B | 0.99 |
| 2020-03-31 | $0.11B | $0.20B | 0.51 |
| 2019-12-31 | $0.10B | $0.20B | 0.51 |
| 2019-09-30 | $0.11B | $0.21B | 0.55 |
| 2019-06-30 | $0.00B | $0.00B | 0.00 |
| 2019-03-31 | $0.00B | $0.00B | 0.00 |
| 2018-12-31 | $0.00B | 0.00 | |
| 2018-09-30 | $0.00B | $0.00B | 0.00 |
| 2017-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.495B | $0.296B |
| Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $9.226B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $5.656B | 176.38 |
| Hims & Hers Health (HIMS) | United States | $5.534B | 140.72 |
| Enovis (ENOV) | United States | $2.608B | 17.68 |
| Privia Health (PRVA) | United States | $2.587B | 215.60 |
| IRhythm Technologies (IRTC) | United States | $2.316B | 0.00 |
| Azenta (AZTA) | United States | $2.209B | 110.15 |
| Omnicell (OMCL) | United States | $2.116B | 69.23 |
| 10x Genomics (TXG) | United States | $1.732B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.689B | 0.00 |
| Schrodinger (SDGR) | United States | $1.518B | 0.00 |
| Phreesia (PHR) | United States | $1.148B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.690B | 0.00 |
| Standard BioTools (LAB) | United States | $0.596B | 0.00 |
| Talkspace (TALK) | United States | $0.583B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.547B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.505B | 87.40 |
| Pulmonx (LUNG) | United States | $0.268B | 0.00 |
| TruBridge (TBRG) | United States | $0.247B | 71.91 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.209B | 0.00 |
| American Well (AMWL) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.076B | 0.00 |
| HeartBeam (BEAT) | United States | $0.074B | 0.00 |
| 111 (YI) | China | $0.052B | 0.00 |
| CareCloud (CCLD) | United States | $0.046B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Zepp Health (ZEPP) | China | $0.037B | 0.00 |
| Movano (MOVE) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.013B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |